Sort
21,281 grants matching “influenza”
Prospective Multicenter Study of Bronchiolitis Admissions: Etiology & Disposition
$883,729Carlos A. Camargo · Massachusetts General Hospital · U01 · FY2008 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS
$883,666Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2020 · AI
Identification and characterization of novel drugs that target the Influenza
$882,792Richard J. Whitley · University Of Alabama At Birmingham · U19 · FY2014 · AI
Development of Aersolized Vaccines
$882,379Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Proteomics, Metabolomics and Lipidomics
$882,015Richard D Smith · University Of Wisconsin-Madison · U19 · FY2016 · AI
Role of the GI microbiome in immune responses to oral SIV-DNA+SIV-polio Vaccine
$881,569Anna Aldovini · Boston Children'S Hospital · R56 · FY2016 · AI
Modeling Host Responses to Understand Severe Human Virus Infections
$881,381Yoshihiro Kawaoka · University Of Wisconsin-Madison · U19 · FY2015 · AI
Fine Mechanisms of Adaptive NK Cell Formation Against HIV and SIV
$881,222Roger Keith Reeves · Duke University · R01 · FY2021 · AI
Deciphering the relationship between structure, dynamics and function in helical bundle proteins
$880,940William F Degrado · University Of California, San Francisco · R35 · FY2018 · GM
Cell lysis-induced leukotriene synthesis activates type-2 immunity in the lung
$880,735Jakob H. Von Moltke · University Of Washington · R01 · FY2025 · HL
Viral Respiratory Pathogens Research Unit
$880,288Robert B Couch · Baylor College Of Medicine · N01 · FY2012 · AI
IL-2 Family Cytokines and their Receptors-- Biology of the IL-21 system
$880,077Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2009 · HL
Project 4 - Influenza - UAB
$879,614Richard J. Whitley · University Of Alabama At Birmingham · U19 · FY2020 · AI
Integrated Services Core
$879,285William Paul Duprex · University Of Pittsburgh At Pittsburgh · UC7 · FY2024 · AI
Impact of Immunotherapy on Viral Immunity in Humans
$879,190Raymond T Chung · Massachusetts General Hospital · U19 · FY2021 · AI
Eritoran (E5564), a TLR4 antagonist, as a novel therapeutic for influenza
$878,832Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2014 · AI
The generation and protective function of lung tissue resident memory T cells following SARS-CoV-2 infection or vaccination
$878,617John Ross Teijaro · Scripps Research Institute, The · R01 · FY2023 · AI
Point of care microfluidic diagnosis system for rapid and sensitive detection of
$878,525Michel G. Bergeron · Laval University · R01 · FY2010 · AI
Project 2: Susceptibility of Lung Cancer Cells to SARS- CoV-2 Infection and Antibody-Mediated Neutralization
$878,495Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U54 · FY2020 · CA
Modulation of Viral Antigen Presentation in the Lung
$878,401Anna Karolina Palucka · Jackson Laboratory · U19 · FY2020 · AI
Translational Geroscience Network
$878,093James L. Kirkland · Mayo Clinic Rochester · R33 · FY2019 · AG
Systems biological analyses of innate responses to vaccination
$877,945Bali Pulendran · Emory University · U19 · FY2012 · AI
In vivo CRISPR engineering of B cells to produce anti-HIV broadly neutralizing antibodies using novel nanoparticles
$877,927Jennifer Eileen Adair · Fred Hutchinson Cancer Center · R01 · FY2022 · AI
Project 1: Perturbation of Pre-Existing Immunity to Chronic Viral Infection Through Immunotherapy
$877,874Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2023 · AI
Increasing available choices for conjugate vaccine technology by producing carrier proteins in Scarab Genomicsâ reduced genome E. coli strains
$877,755Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2017 · AI